Identification of a novel fusion gene MLL-MAML2 in secondary acute myelogenous leukemia and myelodysplastic syndrome with inv(11)(q21q23)

Genes Chromosomes and Cancer

Volumn 46, Issue 9, 2007, Pages 813-819

  Nemoto, Noriko ^a   Suzukawa, Kazumi ^a   Shimizu, Seiichi ^b   Shinagawa, Atsushi ^c   Takei, Naoko ^a   Taki, Tomohiko ^d   Hayashi, Yasuhide ^e   Kojima, Hiroshi ^a   Kawakami, Yasushi ^a   Nagasawa, Toshiro ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b TSUCHIURA KYODO GENERAL HOSPITAL   (Japan)

^c Hitachi   (Japan)

^d KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^e Gumna Children S Medical Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; LUCIFERASE; NOTCH1 RECEPTOR; TRANSCRIPTION FACTOR HES 1;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CASE REPORT; CHROMOSOME 11; CHROMOSOME INVERSION; CONTROLLED STUDY; EXON; FEMALE; FUSION GENE; GENE; HIDRADENOMA; HUMAN; HUMAN CELL; MALE; MAML2 GENE; MLL GENE; MUCOEPIDERMOID TUMOR; MYELODYSPLASTIC SYNDROME; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; WARTHIN TUMOR;

AGED; ANTINEOPLASTIC AGENTS; CHROMOSOMES, HUMAN, PAIR 11; DNA-BINDING PROTEINS; EXONS; FEMALE; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; MYELOID-LYMPHOID LEUKEMIA PROTEIN; NUCLEAR PROTEINS; ONCOGENE PROTEINS, FUSION; PROTEIN STRUCTURE, TERTIARY; TRANSCRIPTION FACTORS;

EID: 34547122715     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20467     Document Type: Article

References (25)

1. Behboudi A, Winnes M, Gorunova L, van den Oord JJ, Mertens F, Enlund F, Srenman G. 2005. Clear cell hidradenoma of the skin-a third tumor type with a t(11;19) - associated TORC1-MAML2 gene fusion. Genes Chromosomes Cancer 43:202-205.
2. Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
3. Enlund F, Behboudi A, Andren Y, Oberg C, Lendahl U, Mark J, Stenman G. 2004. Altered Notch signaling resulring from expression of a WAMTP1-MAML2 gene fusion in mucoepidermoid carcinomas and benign Warthin's rumors. Exp Cell Res 292:21-28.
4. Ichikawa H, Shimizu K, Hayashi Y, Ohki M. 1994. An RNA-binding prorein gene, TLS/FUS, is fused to ERG in human myeloid leukemia with t(16;21) chromosomal translocarion. Cancer Res 54:2865-2868.
5. Itoh F, Itoh S, Goumans MJ, Valdimarsdottir G, Iso T, Dotto GP, Hamamori Y, Kedes L, Kato M, ten Dijke Pr P. 2004. Synergy and antagonism between Notch and BMP receptor signaling pathways in endothelial cells. Embo J 23:541-551.
6. Leong KG, Karsan A. 2006. Recent insights into the role of Notch signaling in tumorigenesis. Blood 107:2223-2233.
7. Li ZY, Liu DP, Liang CC. 2005. New insight into the molecular mechanisms of MLL-associated leukemia. Leukemia 19:183-190.
8. Lin SF, Oyama T, Nagase T, Harigaya K, Kiragawa M. 2002. Identification of new human mastermind proteins defines a family that consists of positive regulators for notch signaling. J Biol Chem 277:50612-50620.
9. Liu H, Chen B, Xiong H, Huang QH, Zhang QH, Wang ZG, Li BL, Chen Z, Chen SJ. 2004. Functional contribution of EEN to leukemogenic transformation by MLL-EEN fusion protein. Oncogene 23:3385-3394.
10. Martin ME, Milne TA, Bloyer S, Galoian K, Shen W, Gibbs D, Brock HW, Slany R, Hess JL. 2003. Dimerization of MLL fusion proteins immortalizes hematopoietic cells. Cancer Cell 4:197-207.
11. Megonigal MD, Rappaport EF, Wilson RB, Jones DH, Whitlock JA, Ortega JA, Slater DJ, Nowell PC, Felix CA. 2000. Panhandle PCR for cDNA: A rapid method for isolation of MLL fusion transcripts involving unknown partner genes. Proc Natl Acad Sci USA 97:9597-9602.
12. Meyer C, Schneider B, Jakob S, Strehl S, Attarbaschi A, Schnittger S, Schoch C, Jansen MW, van Dongen JJ, den Boer ML, Pieters R, Ennas MG, Angelucci E, Koehl U, Greil J, Griesinger F, Zur Stadt U, Eckert C, Szczepanski T, Niggli FK, Schafer BW, Kempski H, Brady HJ, Zuna J, Trka J, Nigro LL, Biondi A, Delabesse E, Macintyre E, Stanulla M, Schrappe M, Haas OA, Burmeister T, Dingermann T, Klingebiel T, Marschalek R. 2006. The MLL recombinome of acute leukemias. Leukemia 20:777-784.
13. Obama K, Furukawa Y, Tara M, Niina K. 1998. Secondary monocytic leukemia with rearrangement of the MLL gene occurring during the course of adult T-cell leukemia. Int J Hematol 68:323-326.
14. Rasio D, Schichman SA, Negrini M, Canaani E, Croce CM. 1996. Complete exon structure of the ALL1 gene. Cancer Res 56:1766-1769.
15. Rowley JD. 1998. The critical role of chromosome translocations in human leukemias. Annu Rev Genet 32:495-519.
16. So CW, Cleary ML. 2003. Common mechanism for oncogenic activation of MLL by forkhead family proteins. Blood 101:633-639.
17. So CW, Lin M, Ayton PM, Chen EH, Cleary ML. 2003. Dimerization contributes to oncogenic activation of MLL chimeras in acute leukemias. Cancer Cell 4:99-110.
18. Suzukawa K, Shimizu S, Nemoto N, Takei N, Taki T, Nagasawa T. 2005. Identification of a chromosomal breakpoint and detection of a novel form of an MLL-AF17 fusion transcript in acute monocytic leukemia with t(11;17)(q23;q21). Int J Hematol 82: 38-41.
19. Takebayashi K, Sasai Y, Sakai Y, Watanabe T, Nakanishi S, Kageyama R. 1994. Structure, chromosomal locus, and promoter analysis of the gene encoding the mouse helix-loop-helix factor HES-1. Negative autoregulation through the multiple N box elements. J Biol Chem 269:5150-5156.
20. Takei N, Suzukawa K, Mukai HY, Itoh T, Okoshi Y, Yoda Y, Nagasawa T. 2006. Therapy-related acute myeloid leukemia 6 years after clonal detection of inv(11)(q21q23) and MLL gene rearrangement. Int J Hematol 83:247-251.
21. Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, Varambally S, Cao X, Tchinda J, Kuefer R, Lee C, Montie JE, Shah RB, Pienta KJ, Rubin MA, Chinnaiyan AM. 2005. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310:644-648.
22. Tonon G, Modi S, Wu L, Kubo A, Coxon AB, Komiya T, O'Neil K, Stover K, El-Naggar A, Griffin JD, Kirsch IR, Kaye FJ. 2003. t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway. Nat Genet 33:208-213.
23. Wu L, Griffin JD. 2004. Modulation of Notch signaling by master-mind-like (MAML) transcriptional co-activators and their involvement in tumorigenesis. Semin Cancer Biol 14:348-356.
24. Wu L, Liu J, Gao P, Nakamura M, Cao Y, Shen H, Griffin JD. 2005. Transforming activity of MECT1-MAML2 fusion oncoprotein is mediated by constitutive CREB activation. EMBO J 24:2391-2402.
25. Wu L, Sun T, Kobayashi K, Gao P, Griffin JD. 2002. Identification of a family of mastermind-like transcriptional coactivators for mammalian notch receptors. Mol Cell Biol 22:7688-7700.